Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

FLUOR DE LYS® HDAC3/NCOR1 fluorometric drug discovery kit

 
BML-AK531-0001 96 wells 656.00 USD
Do you need bulk/larger quantities?
 
  • Useful for inhibitor screening or characterizing enzyme kinetics
  • Includes optimal substrate selected from a panel of acetylated sites in p53 and histones
  • Supplied with enough recombinant enzyme for 96 assays (1 x 96-well plate)
A FLUOR DE LYS® fluorescent assay system. The HDAC3/NCOR1 Fluorescent Activity Assay/Drug Discovery Kit is a complete assay system designed to measure the lysyl deacetylase activity of the recombinant human HDAC3 included in the kit. The kit is ideal for chemical library screening for candidate inhibitors or activators or kinetic assay of the enzyme under varying conditions. The preparation provided with this kit, a complex of HDAC3 with the NCOR1 Deacetylase Activation Domain (DAD), has over 100-fold greater specific activity than recombinant HDAC3 alone and more closely approximates the fully active in vivo form of the enzyme. Another advantage of the complex for drug discovery purposes is the possibility of identifying small molecule disruptors of the HDAC3-DAD interaction. Thus, in addition to active site binding, there is another potential route to inhibition, one more likely to be highly specific to HDAC3. The FLUOR DE LYS® HDAC3/NCOR1 assay is based on the FLUOR DE LYS® Substrate and FLUOR DE LYS® Developer combination. The assay procedure has two steps. First, the FLUOR DE LYS® SIRT1 Substrate, which comprises an acetylated lysine side chain, is incubated with HDAC3/NCOR1. Deacetylation of the substrate sensitizes the substrate so that, in the second step, treatment with the FLUOR DE LYS® Developer II produces a fluorophore.

Product Specification

Alternative Name:Histone deacetylase 3/Nuclear receptor corepressor 1 fluorometric drug discovery kit
 
Applications:Fluorescent detection, HTS
Activity assay, Cell-based assays
 
Use/Stability:Store all components except the microplate and instruction booklet at -70°C for the highest stability. The HDAC3/NCOR1 Complex, Prod. No. BML-KI574, must be handled with particular care in order to retain maximum enzymatic activity. Defrost it quickly in a RT water bath or by rubbing between fingers, then immediately store on an ice bath. The remaining unused enzyme should be refrozen quickly, by placing at -70°C. If possible, snap freeze in liquid nitrogen or a dry ice/ethanol bath. To minimize the number of freeze/thaw cycles, aliquot the enzyme into separate tubes and store at -70°C.
 
Shipping:Shipped on Dry Ice
 
Long Term Storage:-80°C
 
Kit/Set Contains:HDAC3/NCOR1 Complex (human, recombinant) (Prod. No. BML-KI574)
67 µl; 30 ng/µl in 50mM TRIS, pH 8.0, 138mM NaCl, 10% glycerol, 1 mg/ml BSA.
Storage: -70°C; avoid freeze/thaw cycles!
FLUOR DE LYS®−SIRT1, Deacetylase Substrate (Prod. No. BML-KI177)
100 µl; 5mM solution in 50mM TRIS/Cl, pH 8.0, 137mM sodium chloride, 2.7mM potassium chloride, 1mM magnesium chloride.
Storage: -70°C
FLUOR DE LYS® Developer II Concentrate (5x) (Prod. No. BML-KI176)
5 x 250 µl; 5x Stock Solution; dilute in assay buffer before use.
Storage: -70°C
Trichostatin A (HDAC Inhibitor) (Prod. No. BML-GR309-9090) 100 µl; 0.2mM in DMSO (dimethylsulfoxide).
Storage: -70°C
FLUOR DE LYS® Deacetylated Standard (Prod. No. BML-KI142)
30µl; 10mM in DMSO (dimethylsulfoxide).
Storage: -70°C
HDAC Assay Buffer II (Prod. No. BML-KI422)
20 ml; (50 mM TRIS/Cl, pH 8.0, 137mM sodium chloride, 2.7mM potassium chloride, 1mM magnesium chloride, 1mg/ml BSA).
Storage: -70°C
HDAC Assay Buffer (Prod. No. BML-KI143)
20 ml; (50 mM TRIS/Cl, pH 8.0, 137mM sodium chloride, 2.7mM potassium chloride, 1mM magnesium chloride).
Storage: -70°C
1/2 volume microplate (Prod. No. BML-KI101)
Storage: Room temperature
1/2 volume white NBS microplate (Prod. No. BML-KI571)
Storage: Room temperature
 
Scientific Background:In recent years there has been great interest in screening for HDAC inhibitors. Two pan-HDAC inhibitors, Vorinostat (SAHA) and Istodax (romidepsin), are now approved drugs for cutaneous T-cell lymphoma (CTCL). As HDAC isotype-specific inhibitors are sought, there are particularly good reasons to focus on HDAC3. Inhibition of HDAC3 may be the determining factor in the anti-proliferative effects of HDAC inhibitors on cancer cells and its caspase-dependent cleavage and relocation to the cytoplasm may be critical to the progression of apoptosis. The HDAC3/NCOR complex has been found to localize to the mitotic spindle and to be required for its proper formation and regulation. HDAC3, rather than the class II HDACs 4 and 5, is likely the direct deacetylater of MEF2, implying an important role in pathways affecting heart disease. HDAC3/NCOR1 is essential to circadian regulation of metabolism. Mice in which the NCOR1-HDAC3 interaction was disrupted had abnormal clock gene regulation and circadian behavior but were also leaner and more insulin sensitive.
 
UniProt ID:O15379
 

Product Literature References

Influence of the carbamate fungicide benomyl on the gene expression and activity of aromatase in the human breast carcinoma cell line MCF-7: Y. Kawaratani, et al.; Environ. Toxicol. Pharmacol. 39, 292 (2015), Abstract;
Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation: X. Jiang, et al.; J. Mol. Endocrinol. 53, 191 (2014), Abstract;
Identification of highly selective and potent histone deacetylase 3 inhibitors using click chemistry-based combinatorial fragment assembly: T. Suzuki, et al.; PLoS One 8, e68669 (2013), Abstract; Full Text

General Literature References

Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control: S. Bhaskara, et al.; Mol. Cell 30, 61 (2008), Abstract;
Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment: S. Ishii, et al.; PNAS USA 105, 4179 (2008), Abstract;
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology: T. Alenghat, et al.; Nature 456, 997 (2008), Abstract;
Cleavage and cytoplasmic relocalization of histone deacetylase 3 are important for apoptosis progression: F. Escaffit, et al.; Mol. Cell Biol. 27, 554 (2007), Abstract;
Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2: S. Gregoire, et al.; Mol. Cell Biol. 27, 1280 (2007), Abstract;
Purification of a histone deacetylase complex from Xenopus laevis: preparation of substrates and assay procedures: P.A. Wade, et al.; Methods Enzymol. 304, 715 (1999), Abstract;
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p: J. Taunton, et al.; Science 272, 408 (1996), Abstract;
Enzymatic deacetylation of histone: A. Inoue & D. Fujimoto; BBRC 36, 146 (1969), Abstract;

Related Literature

Brochures
Stem Cells
Stem Cells
Download as PDF

Brochures
Epigenetics
Epigenetics
Download as PDF

Catalogs
Diabetes Catalog
Diabetes Catalog
Download as PDF

All new literature pieces

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,